ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer
Colorectal cancer (CRC) has a 5-year survival rate of <10%, as it can metastasize to the lungs and liver. Anticancer drugs and targeted therapies used to treat metastatic colorectal cancer have insufficient therapeutic efficacy and are associated with complications. Therefore, research to develop...
Main Authors: | Kang, J.-H (Author), Kim, S. (Author), Kim, Y.-J (Author), Lee, S.-J (Author), Lim, E.-J (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
A study of Src kinase in the regulation of metastatic progression in colorectal cancer
by: Jones, Robert John
Published: (2002) -
SRC kinase regulation in progressively invasive cancer.
by: Weichen Xu, et al.
Published: (2012-01-01) -
Regulation of spermatogenesis by intercellular adhesion molecules (ICAMS) and sarcoma (SRC) family kinases
by: Xiao, Xiang, et al.
Published: (2013) -
Analysis of SDF-1-induced promoter activity of ICAM-1 gene in colorectal cancer cells
by: LI Yue Hong, et al.
Published: (2011) -
Transcriptional regulation of the SRC12 and SRC1A promoters in human cancer cell lines
by: Dehm, Scott Michael
Published: (2003)